Through its interaction with cannabinoid receptors 1 and 2 (CB1R and CB2R), this system has been proposed as a target for several obesity treatments (Miralpeix et al, 2021). The gene discussed is CNR1; the disease is obesity due to melanocortin 4 receptor deficiency.